Brn	0	3	B-Gene_or_gene_product
-	3	4	I-Gene_or_gene_product
3a	4	6	I-Gene_or_gene_product
,	6	7	O
a	8	9	O
neuronal	10	18	O
transcription	19	32	O
factor	33	39	O
of	40	42	O
the	43	46	O
POU	47	50	O
gene	51	55	O
family	56	62	O
:	62	63	O
indications	64	75	O
for	76	79	O
its	80	83	O
involvement	84	95	O
in	96	98	O
cancer	99	105	B-Pathological_formation
and	106	109	O
angiogenesis	110	122	O
.	122	123	O

Brn	125	128	B-Gene_or_gene_product
-	128	129	I-Gene_or_gene_product
3a	129	131	I-Gene_or_gene_product
,	131	132	O
a	133	134	O
member	135	141	O
of	142	144	O
the	145	148	O
POU	149	152	O
gene	153	157	O
family	158	164	O
(	165	166	O
so	166	168	O
-	168	169	O
called	169	175	O
because	176	183	O
of	184	186	O
the	187	190	O
similarity	191	201	O
with	202	206	O
the	207	210	O
group	211	216	O
of	217	219	O
transcription	220	233	O
factors	234	241	O
Pit	242	245	B-Gene_or_gene_product
,	245	246	O
Oct	247	250	B-Gene_or_gene_product
,	250	251	O
and	252	255	O
Unc	256	259	B-Gene_or_gene_product
)	259	260	O
,	260	261	O
was	262	265	O
found	266	271	O
in	272	274	O
neuronal	275	283	B-Cell
cells	284	289	I-Cell
engaged	290	297	O
in	298	300	O
the	301	304	O
transcription	305	318	O
activity	319	327	O
of	328	330	O
the	331	334	O
p1	335	337	B-DNA_domain_or_region
and	338	341	O
p2	342	344	B-DNA_domain_or_region
promoters	345	354	I-DNA_domain_or_region
of	355	357	O
the	358	361	O
most	362	366	O
powerful	367	375	O
antiapoptotic	376	389	O
gene	390	394	O
,	394	395	O
namely	396	402	O
,	402	403	O
Bcl	404	407	B-Gene_or_gene_product
-	407	408	I-Gene_or_gene_product
2	408	409	I-Gene_or_gene_product
.	409	410	O

The	411	414	O
alternative	415	426	O
splicing	427	435	O
of	436	438	O
Brn	439	442	B-Gene_or_gene_product
-	442	443	I-Gene_or_gene_product
3a	443	445	I-Gene_or_gene_product
mRNA	446	450	O
produces	451	459	O
two	460	463	O
molecular	464	473	O
forms	474	479	O
:	479	480	O
a	481	482	O
longer	483	489	O
,	489	490	O
Bcl	491	494	B-Gene_or_gene_product
-	494	495	I-Gene_or_gene_product
2	495	496	I-Gene_or_gene_product
transactivating	497	512	O
form	513	517	O
,	517	518	O
and	519	522	O
a	523	524	O
shorter	525	532	O
inactive	533	541	O
form	542	546	O
,	546	547	O
lacking	548	555	O
84	556	558	O
AA	559	561	O
in	562	564	O
the	565	568	O
aminoterminus	569	582	O
.	582	583	O

In	584	586	O
neuronal	587	595	B-Cell
cells	596	601	I-Cell
,	601	602	O
following	603	612	O
Brn	613	616	B-Gene_or_gene_product
-	616	617	I-Gene_or_gene_product
3a	617	619	I-Gene_or_gene_product
gene	620	624	O
transfection	625	637	O
and	638	641	O
superexpression	642	657	O
,	657	658	O
an	659	661	O
increase	662	670	O
of	671	673	O
30	674	676	O
fold	677	681	O
of	682	684	O
the	685	688	O
Bcl	689	692	B-Gene_or_gene_product
-	692	693	I-Gene_or_gene_product
2	693	694	I-Gene_or_gene_product
protein	695	702	O
occurs	703	709	O
,	709	710	O
leading	711	718	O
to	719	721	O
apoptosis	722	731	O
protection	732	742	O
.	742	743	O

However	744	751	O
,	751	752	O
recent	753	759	O
works	760	765	O
demonstrate	766	777	O
that	778	782	O
Brn	783	786	B-Gene_or_gene_product
-	786	787	I-Gene_or_gene_product
3a	787	789	I-Gene_or_gene_product
expression	790	800	O
is	801	803	O
not	804	807	O
restricted	808	818	O
to	819	821	O
neuronal	822	830	B-Cell
cells	831	836	I-Cell
,	836	837	O
as	838	840	O
its	841	844	O
activity	845	853	O
was	854	857	O
detected	858	866	O
also	867	871	O
in	872	874	O
cancer	875	881	B-Cell
cells	882	887	I-Cell
of	888	890	O
non	891	894	O
-	894	895	O
neuronal	895	903	O
nature	904	910	O
.	910	911	O

Looking	912	919	O
for	920	923	O
mechanisms	924	934	O
linking	935	942	O
Brn	943	946	B-Gene_or_gene_product
-	946	947	I-Gene_or_gene_product
3a	947	949	I-Gene_or_gene_product
to	950	952	O
carcinogenesis	953	967	O
,	967	968	O
we	969	971	O
discuss	972	979	O
the	980	983	O
role	984	988	O
of	989	991	O
this	992	996	O
transcription	997	1010	O
factor	1011	1017	O
in	1018	1020	O
influencing	1021	1032	O
Bcl	1033	1036	B-Gene_or_gene_product
-	1036	1037	I-Gene_or_gene_product
2	1037	1038	I-Gene_or_gene_product
/	1038	1039	O
p53	1039	1042	B-Gene_or_gene_product
antagonism	1043	1053	O
and	1054	1057	O
Bcl	1058	1061	B-Gene_or_gene_product
-	1061	1062	I-Gene_or_gene_product
2	1062	1063	I-Gene_or_gene_product
/	1063	1064	O
VEGF	1064	1068	B-Gene_or_gene_product
induction	1069	1078	O
of	1079	1081	O
tumor	1082	1087	B-Pathological_formation
angiogenesis	1088	1100	O
,	1100	1101	O
concluding	1102	1112	O
this	1113	1117	O
review	1118	1124	O
with	1125	1129	O
a	1130	1131	O
proposal	1132	1140	O
for	1141	1144	O
the	1145	1148	O
oncogenic	1149	1158	O
nature	1159	1165	O
of	1166	1168	O
Brn	1169	1172	B-Gene_or_gene_product
-	1172	1173	I-Gene_or_gene_product
3a	1173	1175	I-Gene_or_gene_product
.	1175	1176	O

